Tag: Nowinski
Drug developer exceeds financing target
ContraFect Corp. raises critical financing for clinical stage drug development.
Businesses build a bridge from China to Yonkers
A leading business group in China is a new equity investor in Contrafect Corp. in Yonkers.
Yonkers drug developer ready for first human trials
Contrafect Corp., a Yonkers-based biotechnology company, prepares to begin clinical trials on humans of its first bacteria-killing drug.
Building on biotech in Yonkers
An early-stage biotech company led by an industry pioneer will begin operations this spring in downtown Yonkers.
